HEMOPHILIA A AND B
-
Hemophilia A gene therapy approved in Europe but possibly delayed in the U.S.
Last August, the European Medicines Agency (EMA) granted conditional marketing authorization to BioMarin’s Roctavian (valoctocogene roxaparvovec) gene therapy for the treatment of severe hemophilia A...
-
Hemophilia B gene therapy approved by U.S. FDA
Montreal – November 28, 2022 – The U.S. Food and Drug Administration (FDA) approved the first gene therapy for hemophilia B on November 22. Etranacogene...
-
Commemoration of the tainted blood tragedy
The tainted blood tragedy is incontestably the worst public health disaster that Canada has ever faced. Today, October 27, anniversary of the creation of the...
-
Unburying My Father: The life and photography of Randy Masser
by Zander Masser, Montreal, QC On a fall day in 1996, my parents called a family meeting. I was 11 years old. My brother was...
-
CHS Research programs – Time to apply!
The CHS is announcing its Call for Applications for its research programs for the 2023-2024 grant period. The deadline to submit applications for all the...